Correction: Discovery of Entrectinib: A New 3-Aminoindazole as a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor (Journal of Medicinal Chemistry (2016) 59: 7 (3392-3408) DOI: 10.1021/acs.jmedchem.6b00064)
Access
Citation
ID:
92814
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
92814
Unique Identifier:
10.1021/acs.jmedchem.9b01259
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Blockchain Upload Locked
Complete all 5 checklist items to tokenize your article